Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

NCT03681561 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

DRUG: Ruxolitinib
DRUG: Nivolumab

Sponsor

Veronika Bachanova

Collaborators

[object Object]
[object Object]